Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Clinical trial NCT07502508 · RECRUITING

Trial details

NCT number: NCT07502508
Sponsor: Biomea Fusion Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2026-04-30
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.